200
Participants
Start Date
March 1, 2022
Primary Completion Date
December 31, 2024
Study Completion Date
December 31, 2025
Liposomal Bupivacaine
20cc of Liposomal Bupivacaine for TAP block
Bupivacaine
20cc of Bupivacaine for TAP block
Karl LeBlanc, Baton Rouge
Our Lady of the Lake Hospital
OTHER
Leslie Son
OTHER